MedTrace Logo

MS-ResearchBiomarkerS

NCT05204459 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-02-06

No results posted yet for this study

Summary

This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.

Conditions

  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Multiple Sclerosis, Primary Progressive
  • Multiple Sclerosis, Secondary Progressive
  • Clinically Isolated Syndrome
  • Radiologically Isolated Syndrome
  • Neuromyelitis Optica Spectrum Disorders
  • Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
  • Neurologic Autoimmune Disease
  • Neurologic Disorder
  • Healthy Aging

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Omar Al-Louzi, MD · Cedars-Sinai Medical Center

  • Marwa Kaisey, MD · Cedars-Sinai Medical Center

  • Brooke Guerrero, MD · Cedars-Sinai Medical Center

  • Laura Locke, CRNP · Cedars-Sinai Medical Center

  • Pascal Sati, PhD · Cedars-Sinai Medical Center

  • Nancy Sicotte, MD · Cedars-Sinai Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-11
Primary Completion
2041-11-11
Completion
2041-11-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05204459 on ClinicalTrials.gov